Norway’s DNV GL Designated as 10th Notified Body Under MDRClinical Trials With Conditions

Europe – EU issues implementing regs for devices without an intended medical purpose

Regulation (EU) 2017/745 lays down rules concerning the placing on the market, making available on the market or putting into service of medical devices...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical devices: UK approved bodies

Approved bodies under Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) for medical devices...

Europe – Annual report 2023

The Management Board’s oversight role covers the full range of EMA programmes and activities, making sure that the Agency works effectively and co-operates successfully...

Europe – GUIDANCE on the content and structure of the summary of the...

This document is intended to provide Commission guidance, in accordance with Article 77(6) of Regulation (EU) 2017/745 of the European Parliament and of the Council of...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2023-7 Guidance on exemptions from the requirement to perform clinical investigations...

In the case of implantable devices and class III devices, clinical investigations shall be performed, except if: — the device has been designed by modifications of...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Normes Harmonisées 2024/817

La décision d’éxecution (EU) 2024/817 de 6 mars 2024 met à jour la liste des Normes Harmonisées relatives à la stérilisation des produits de...
Advice for Management of Clinical trials in relation to Coronavirus

UK – Exceptional use of non-UKCA marked medical devices

A manufacturer can apply to supply a medical device that does not comply with the law to protect a patient’s health if there is...

Europe – Update : MDCG 2022-9 rev.1 – Summary of safety and performance template...

Regulation (EU) 2017/746 on in vitro diagnostic medical devices (the IVDR) requires that the manufacturer shall draw up a summary of safety and performance (SSP)...
Opinion On Allergy Alert Test (AAT) as a proof-of-concept study

Europe – Phthalates in certain medical devices: updated SCHEER guidelines published

Today, following a request from the European Commission, the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) provided the update of their guidelines on...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – MHRA expected to launch recognition framework for devices

According to Richard Phillips, executive director of the Association of British HealthTech Industries (ABHI), the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is...

NOS PROCHAINES FORMATIONS